Global Morcellators Market, By Type (Electric Morcellator, Manual Morcellator, and Others), Application (Uterine Fibroids, Hysteroscopy, Laparoscopy, and Others), Usage Type (Reusable, Reposable, and Disposable), End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others) – Industry Trends and Forecast to 2031.
Morcellators Market Analysis and Size
Laparoscopic hysterectomy, a minimally invasive surgical procedure to remove the uterus, is a key application of the morcellators market. Morcellators are used to fragment the uterus into smaller pieces, allowing it to be extracted through small incisions rather than a large open cut. This technique reduces surgical trauma, minimizes scarring, and shortens recovery time for patients. The use of morcellators in laparoscopic hysterectomy has gained popularity due to these benefits, driving demand in the medical device market.
The global morcellators market size was valued at USD 132.90 million in 2023 and is projected to reach USD 237.02 million by 2031, with a CAGR of 7.5% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Electric Morcellator, Manual Morcellator, and Others), Application (Uterine Fibroids, Hysteroscopy, Laparoscopy, and Others), Usage Type (Reusable, Reposable, and Disposable), End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
BLUE ENDO (U.S.), Karl Storz (Germany), Richard Wolf GmbH (Germany), Franklin Templeton. (U.S.), Lumenis Be Limited (Israel), Hologic Inc. (U.S.), Smith+Nephew (U.S.), Olympus Corporation (Japan), Nouvag (Germany), LiNA Medical ApS (Denmark), Medtronic (Ireland), Stryker (U.S.), Cook (U.S.), BD (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Morcellators are medical devices used during minimally invasive surgeries to cut larger tissues into smaller pieces, making them easier to remove from the body. They are commonly used in procedures such as laparoscopic hysterectomies and myomectomies to extract uterine fibroids or other growths through small incisions.
Morcellators Market Dynamics
Drivers
- Growing Preference for Minimally Invasive Surgeries
Patients and healthcare providers favor these procedures due to their numerous benefits, including reduced postoperative pain, shorter hospital stays, quicker recovery times, and minimal scarring. These advantages lead to increased patient satisfaction and improved surgical outcomes. As a result, there is a higher demand for advanced surgical tools such as morcellators, which facilitate these less invasive techniques, thereby propelling market growth. This trend is particularly prominent in gynecological surgeries, such as laparoscopic hysterectomy and myomectomy.
- Increasing Prevalence of Gynecological Disorders
The increasing prevalence of gynecological disorders, such as uterine fibroids and endometriosis often require surgical intervention, and the growing number of cases heightens the demand for effective treatment options. Morcellators, which facilitate minimally invasive procedures such as laparoscopic hysterectomy and myomectomy, offer a less invasive alternative to traditional open surgeries. As more women seek treatment for these disorders, the adoption of morcellators in surgical practices is expected to rise, driving market growth.
Opportunities
- Expanding Healthcare Infrastructure
As healthcare facilities improve and expand, particularly in emerging economies, there is greater access to advanced surgical procedures and technologies such as minimally invasive surgeries using morcellators. These developments enable healthcare providers to offer more sophisticated treatment options to patients suffering from conditions such as uterine fibroids and other gynecological disorders. Additionally, enhanced infrastructure supports the training of healthcare professionals in the use of morcellators, increasing their adoption and utilization in various surgical settings.
- Rising Advancements in Medical Technology
Advancements in medical technology have led to the development of safer, more precise, and efficient morcellator devices. The improvements in blade design and tissue containment systems reduce the risk of complications such as tissue dissemination and infection. Furthermore, technological advancements have enabled the integration of advanced imaging technologies, such as ultrasound and MRI, which assist surgeons in better targeting tissues for morcellation. Enhanced materials and ergonomic designs also contribute to easier handling and improved patient outcomes, encouraging healthcare providers to adopt morcellators for minimally invasive surgeries such as laparoscopic hysterectomy and myomectomy.
Restraints/Challenges
- Growing Safety Concerns
Growing safety concerns is the potential for morcellation to spread undiagnosed malignant tissue, such as uterine sarcomas, which can significantly worsen patient outcomes. This has prompted regulatory agencies to issue warnings and guidelines regarding the use of morcellators, impacting their adoption in clinical practice. Healthcare providers and patients alike are increasingly cautious due to these safety risks, leading to decreased confidence and utilization of morcellation techniques, especially in cases where malignancy cannot be definitively ruled out preoperatively.
- Stringent Regulatory Requirements
Regulatory bodies, concerned about the potential risks associated with morcellation, have implemented stringent guidelines and safety standards. These requirements often mandate thorough clinical evaluations, rigorous testing of device efficacy and safety, and strict reporting of adverse events. Compliance with these regulations can be time-consuming and costly for manufacturers, leading to delays in product approvals or market entry. Moreover, regulatory scrutiny can deter healthcare providers from adopting morcellators, particularly in regions where concerns over safety and efficacy are heightened.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In September 2019, Medtronic launched the Evolut PRO+ transcatheter aortic valve replacement (TAVR) system in the U.S. TAVR is a minimally invasive procedure used to treat severe aortic stenosis in patients who are at high risk for traditional open-heart surgery. The Evolut PRO+ system builds upon previous generations with enhanced features aimed at improving valve performance and patient outcomes, expanding treatment options for individuals with severe aortic valve disease
- In September 2019, Abbott initiated the TRILUMINATE pivotal trial for its TriClip transcatheter tricuspid valve repair system. This system is designed to address tricuspid regurgitation, a condition where blood flows backwards into the right atrium due to improper closure of the tricuspid valve. The TriClip procedure aims to reduce regurgitation and improve heart function without the need for open-heart surgery, offering a less invasive treatment option for patients suffering from this challenging valve disorder
Morcellators Market Scope
The market is segmented on the basis of type, application, usage type and end use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Electric Morcellator
- Hysteroscopic Morcellator
- Laparoscopic Morcellator
- Manual Morcellator
- Others
Usage Type
- Reusable
- Reposable
- Disposable
Application
- Uterine Fibroids
- Hysteroscopy
- Laparoscopy
- Others
End Use
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Morcellators Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, type, application, usage type and end use as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.
North America dominates the market is attributed to its robust healthcare infrastructure and significant advancements in laparoscopic technology. These factors ensure high-quality medical care and widespread adoption of innovative surgical tools. Additionally, strong investments in healthcare and a focus on minimally invasive procedures further bolster the region's leading position in this market.
Asia-Pacific is expected to experience the highest growth rate in the market due to increasing health awareness among the population and a growing demand for advanced medical technologies. As people become more conscious of their health, there is a greater emphasis on adopting innovative medical solutions, propelling market growth in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Morcellators Market Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- BLUE ENDO (U.S.)
- Karl Storz (Germany)
- Richard Wolf GmbH (Germany)
- Franklin Templeton. (U.S.)
- Lumenis Be Limited (Israel)
- Hologic Inc. (U.S.)
- Smith+Nephew (U.S.)
- Olympus Corporation (Japan)
- Nouvag (Germany)
- LiNA Medical ApS (Denmark)
- Medtronic (Ireland)
- Stryker (U.S.)
- Cook (U.S.)
- BD (U.S.)
SKU-